Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Burt, V. K. Articles by Muntean, E. Search for Related Content PubMed Citation Articles by Burt, V. K. Articles by Muntean, E. Gender Other Treatment Other Delivery of Care

The Use of Psychotropic Medications During Breast-Feeding

OBJECTIVE: The authors reviewed the risks and benefits regarding the use of psychiatric medications during breast-feeding as they relate to the health and well-being of mothers and their infants. Strategies are discussed to limit infant exposure to a medication while effectively treating the nursing mother. METHOD: A MEDLINE search of the literature since 1955 was conducted to determine the use of psychotropic medications in breast-feeding women. Search items included each of the categories of psychopharmacologic agents as well as each of the agents in association with nursing, breast-feeding, postpartum, lactation, and breast milk. RESULTS: No controlled studies on the safety of psychotropic medications in nursing mothers were found. Case reports and small case series for each of the different psychotropic medications serve as the basis for suggested treatment guidelines for the management of psychiatric illnesses in breast-feeding women. Thus, each case needs to be considered on an individual basis, with a thoughtful analysis of the risks and benefits of nursing and exposure of the infant to medication. The baseline clinical status of the infant should also be reviewed. CONCLUSIONS: Women are vulnerable postpartum to psychiatric disorders and frequently face the need to decide whether to take psychotropic medications while breast-feeding. Should psychiatric medication be indicated, the parents should be provided with the available information regarding the effects of these medications on the neonate. In this way, an informed decision can be made. When psychotropic medication is used during breast-feeding, it is strongly recommended that the infant’s pediatrician be involved in monitoring the infant.

This article has been cited by other articles:

				J. L. Payne Antidepressant Use in the Postpartum Period: Practical Considerations Am J Psychiatry, September 1, 2007; 164(9): 1329 - 1332. [Full Text] [PDF]

				D. Kohen Psychotropic medication and breast-feeding Advan. Psychiatr. Treat., September 1, 2005; 11(5): 371 - 379. [Abstract] [Full Text] [PDF]

				E. L. Moses-Kolko, D. Bogen, J. Perel, A. Bregar, K. Uhl, B. Levin, and K. L. Wisner Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications JAMA, May 18, 2005; 293(19): 2372 - 2383. [Abstract] [Full Text] [PDF]

				W. Aichhorn, C. Stuppaeck, and A. B. Whitworth Risperidone and breast-feeding J Psychopharmacol, March 1, 2005; 19(2): 211 - 213. [Abstract] [PDF]

				T. F. Oberlander, R. E. Grunau, C. Fitzgerald, M. Papsdorf, D. Rurak, and W. Riggs Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure Pediatrics, February 1, 2005; 115(2): 411 - 425. [Abstract] [Full Text] [PDF]

				W. AICHHORN, A. B. WHITWORTH, U. WEISS, and C. STUPPAECK Mirtazapine and Breast-Feeding Am J Psychiatry, December 1, 2004; 161(12): 2325 - 2325. [Full Text] [PDF]

				M. V. Seeman Gender Differences in the Prescribing of Antipsychotic Drugs Am J Psychiatry, August 1, 2004; 161(8): 1324 - 1333. [Abstract] [Full Text] [PDF]

				V. Hendrick Treatment of postnatal depression BMJ, November 1, 2003; 327(7422): 1003 - 1004. [Full Text] [PDF]

				S. Y. El-Ibiary and K. C. Lee Novel Uses of Selective Serotonin Reuptake Inhibitors in Women Journal of Pharmacy Practice, June 1, 2003; 16(3): 191 - 199. [Abstract] [PDF]

				P. O. Anderson, S. L. Pochop, and A. S. Manoguerra Adverse Drug Reactions in Breastfed Infants: Less Than Imagined Clinical Pediatrics, May 1, 2003; 42(4): 325 - 340. [Abstract] [PDF]

				L. H. Chaudron Postpartum Depression: What Pediatricians Need to Know Pediatr. Rev., May 1, 2003; 24(5): 154 - 161. [Full Text] [PDF]

				R. M.A. Hirschfeld, C. L. Bowden, M. J. Gitlin, P. E. Keck, R. H. Perlis, T. Suppes, M. E. Thase, and K. D. Wagner Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision) Focus, January 1, 2003; 1(1): 64 - 110. [Full Text] [PDF]

				V. Hendrick and L. Altshuler Management of Major Depression During Pregnancy Am J Psychiatry, October 1, 2002; 159(10): 1667 - 1673. [Full Text] [PDF]

				Psychotropics in Breast-Feeding Mothers Journal Watch Psychiatry, October 18, 2001; 2001(1018): 11 - 11. [Full Text]

				Psychotropics in Breast-Feeding Mothers Journal Watch Women's Health, September 6, 2001; 2001(906): 7 - 7. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us